Form 4: Medifast Director Xian Ming Reports Acquisition of Restricted Stock Units

Director Xian Ming acquired 10,149 restricted stock units of Medifast, Inc. related to director fees, vesting on June 20, 2025.

Summary

• Director Xian Ming reported the acquisition of 10,149 restricted stock units (RSUs) of Medifast, Inc. on June 20, 2024.
• These RSUs are related to the director's deferred compensation plan and represent the contingent right to receive shares of Medifast common stock or the cash equivalent.
• The RSUs will vest in full on June 20, 2025.
• The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.
• Following the transaction, Xian Ming beneficially owns 14,961.918 shares of Medifast.

Sentiment

Score: 7

Explanation: Routine director compensation disclosure; positive as it aligns director interests with shareholders.

Positives

• The acquisition of RSUs aligns the director's interests with those of the shareholders.
• The vesting period of one year encourages long-term commitment.

Future Outlook

The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.

Industry Context

Director compensation through stock and equity grants is a common practice in publicly traded companies to align management's interests with shareholder value.

Comparison to Industry Standards

• Director compensation packages vary widely across the industry, but equity-based compensation is a common component.
• Companies like Herbalife and Nu Skin also utilize stock options and restricted stock units as part of their director compensation plans.
• The specific amount and vesting schedules depend on company size, performance, and industry benchmarks.

Stakeholder Impact

• The acquisition of RSUs by a director can be viewed positively by shareholders as it aligns management's interests with the company's long-term success.

Key Dates